Great Debates & Updates in Hematologic Malignancies is a multi-day, debate driven conference focusing on the treatment of blood cancer. The unique agenda provides opportunities to hear both sides of a current or controversial topic, allowing attendees to form well-rounded opinions based on the comprehensive research and analysis.
With in-person and virtual options, attendees will have several opportunities to network with the expert faculty and industry leaders while learning about the significant advances in myeloma, leukemia, and lymphoma.
Audience discussion is encouraged, with insight on how this impacts their current practice.
The agenda features a mix of clinical updates and lively debates on provocative scientific topics impacting the field, such as multiple myeloma, acute and chronic lymphocytic and myeloid leukemia, lymphoma, and so much more.
These live educational activities are designed to meet the educational needs of those who are involved and/or interested in the treatment of patients with multiple myeloma, lymphoma, acute and chronic lymphocytic leukemia, and myeloid malignancies.
As an event best known for its unique, debate-style format, the agenda features a mix of didactic lectures and debates, examining the latest and most controversial topics across the board in the field of hematologic malignancies.
Robert H. Lurie Comprehensive Cancer Center
Northwestern University
Chicago, Illinois
Chair (Interim), Weill Department of Medicine
Richard T. Silver Distinguished Professor of Hematology and Medical Oncology
Weill Cornell Medicine/New York Presbyterian
New York, New York
Translational Genomics Research Institute, City of Hope Cancer Center
Phoenix, Arizona
